Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial

Autor: Azuma, Arata, Chung, Lorinda, Behera, Digambar, Chung, Melody, Kondoh, Yasuhiro, Ogura, Takashi, Okamoto, Masaki, Swarnakar, Rajesh, Zeng, Xiaofeng, Zou, Heijan, Meng, Xianhua, Gahlemann, Martina, Alves, Margarida, Kuwana, Masataka
Zdroj: In Respiratory Investigation March 2021 59(2):252-259
Databáze: ScienceDirect